References
- Borel J F, Kis Z L. The discovery and development of cyclosporine (Sandimmune). Transplant Proc 1991; 23: 1867–1874
- Calne R Y, Rolles K, White D JG, Thiru S, Evans D B, McMaster P, et al. Cyclosporin A initially as the only immunosup-pressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet 1979, (II): 1033–1036
- European Multicentre Trial Group. European Multicentre Trial of Cyclosporin (Sandimmun®) in Renal Transplantation: 10 years follow-up. Transplant Proc 1993, in press
- Stiller C R, Opelz G. Should cyclosporine be continued indefinitely?. Transplant Proc 1991; 23(1)36–40
- Borel J F. Pharmacology of Cyclosporine (Sandimmun®). IV. Pharmacological properties in vivo. Pharmacol Rev 1989; 41: 318–332
- Second Congress on Immunointervention in Autoimmune Diseases, Paris, France, May 1991. J Autoimmunity 1992; 5, Suppl A
- Hess A D, Colombani P M. Mechanism of action: in vitro studies. Ciclosporin, J F Borel. (Series ‘Progress in Allergy’, Vol. 38), Karger, Basel/Munchen/Paris/London/New York/New Delhi/Singapore/Tokyo/Sydney 1986; 198–221, 1986
- Schreiber S L, Crabtree G R. The mechanism of action of cyclosporin A and FK 506. Immunol Today 1992; 13: 136–142
- Herrmann B, Müller W. Die Therapie der chronischen Polyarthritis mit Cyclosporin A, einem neuen Immunosuppressivum. Akt Rheumatol 1979; 4: 173–186
- Nussenblatt R B, Rodriques M M, Wacker W B, Cevario S J, Salinas-Carmona M C, Gery I, Cyclosporin A. Inhibition of experimental autoimmune uveitis in Lewis rats. J Clin Invest 1981; 67: 1228–1231
- Chapter: Uveitis and Behçet's Disease. Ciclosporin in Autoimmune Diseases. Proc 1st Int Symp, Basel, March 18–20, 1985, R Schindler. Springer Verlag, Berlin/Heidelberg/New York/Tokyo 1985; 133–167
- BenEzra D, Nussenblatt R B, Timonen P. Optimal use of Sandimmun in Endogenous Uveitis. Springer Verlag. 1988
- Ciclosporin in Autoimmune Diseases. Proc 1st Int Symp, Basel, March 18–20, R Schindler. Springer Verlag, Berlin/Heidelberg/New York/Tokyo 1985; 74–79
- Von Graffenried B, Harrison W B. Renal function in patients with autoimmune diseases treated with cyclosporine. Transplant Proc 1985; 17((4))215–231, (Suppl 1)
- Anonymus. A consensus report: cyclosporin A therapy for psoriasis. Br J Dermatol 1990; 122: 1–3, (Suppl 36)
- Feutren G, Von Graffenried B. Cyclosporin A: Pharmacology and therapeutic use in autoimmune diseases. Immunopharmacology in Autoimmune Diseases and Transplantation, H. E. Rugstad, et al. Plenum Press, New York 1992
- Bach J F. Immunointervention in autoimmune diseases: from cellular selectivity to autoantigen specificity. J Autoimmunity 1992; 5: 3–10, (Suppl A)
- Dougados M, Awada H, Amor B. Cyclosporin in rheumatoid arthritis: a double-blind placebo-controlled trial in 52 patients. Br J Rheumatol 1987; 26: 98, (Suppl 2), Abstr No FR 4.
- Tugwell P, Bombardier C, Gent M, Bennett K J, Bensen W G, Carette S, et al. Low-dose cyclosporin versus placebo in patients with rheumatoid arthritis. Lancet 1990; 335: 1051–1055
- Forre O. Cyclosporin A (Sandimmun) in rheumatoid arthritis: A double-blind placebo-controlled study. Scand J Rheumatol 1990; 57, (Suppl 85)
- Timonen P, Friend D, Abeywickrama K, Laburte C, Von Graffenried B, Feutren G. Efficacy of low-dose cyclosporin A in psoriasis: results of dose-finding studies. Br J Dermatol 1990; 122: 33–39, (Suppl 36)
- Mihatsch M J, Wolff K. Report of a Meeting. Consensus conference on cyclosporin A for psoriasis February 1992. Br J Dermatol 1992; 126: 621–623
- Sowden J M, Berth-Jones J, Ross J S, Motley R J, Marks R, Finlay A Y, et al. Double-blind controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis. Lancet 1991; 338: 137–140